Abstract
Objective: To study physicians' opinions on community pharmacists' involvement in counselling patients on use of psychotropic medication. Design: A postal questionnaire with open‐ended questions completed by physicians. Subjects: A six per cent random sample (n=759) of the members of the Finnish Medical Association representing physicians working in hospitals, community health centres, private practices and occupational health services (response rate 64%, n=487). Main measures: Physicians' opinions concerning community pharmacists' involvement in counselling patients about purpose of the medication and adverse effects of benzodiazepines and neuroleptics. Results: When classifying opinions into five categories, majority (72%) of the physicians regarded community pharmacists as a provider of comprehensive or at least general information about adverse effects of benzodiazepines, but only 43% about the purpose of the medication. Correspondingly, 60% of the physicians regarded community pharmacists as a provider of comprehensive or general information about adverse effects of neuroleptics, but only 35 % about the purpose of the medication. There was a strong correlation between physicians' opinions concerning pharmacists' involvement in counselling patients about the purpose of the medication of benzodiazepines and neuroleptics (Spearman's coefficient 0.667), and about adverse effects of both type of medication (0.668). Male physicians had more fixed opinions, both positive and negative, than female physicians. Conclusion: Finnish physicians are still quite critical about community pharmacists involvement in counselling patients on psychotropic medication. Especially with neuroleptics, physicians feel that pharmacists should be cautious when discussing the purpose of the medication if it is excluded from the prescription.
This is a preview of subscription content, log in via an institution to check access.
References
Kessler DA, Communicating with patients about their medications. N Engl J Med 1991;325:1650-2
Airaksinen M, Vainio K, Koistinen J, Ahonen R, Wallenius S, Enlund H. Do the public and pharmacists share opinions about drug information. Int Pharm J 1994;8:168-70.
Spronk VRA, Warmenhoven NE. Patient education in general practice: Opinions of general practitioners. Patient Educ Couns 1983;5:68-75
De Tullio PL, Eraker SA, Jepson C, Becker MH, Fujimoto E, Diaz CL, et al. Patient medication instruction and provider interactions: Effect on knowledge and attitudes. Health Educ Q 1986;13(1):51-60.
Griffin JP, Griffin JR. Informing the patient. J R Coll Physicians Lond 1996;30:107-11.
Airaksinen M, Ahonen R, Enlund H. Drug information from pharmacies: desire for more spontaneous information. Med Care 1993;31:846-50.
Cosler LE, Schulz RM, Baldwin HJ, Cohen SH. Consumer preference for personal drug information source: relationship to perceived importance of drug class. Drug Intell Clin Pharmacol 1986;20:138-42.
Morris LA, Tabak ER, Gondek K. Counseling patients about prescribed medication 12-year trends. Med Care 1997;35:996-1007.
Vainio K, Airaksinen M, Pesonen T, Enlund H. Pharmacy As a Source of Drug Information – Increase in Importance During Ten Years. J Soc Adm Pharm 1999;16:110-111.
Medicaid program; Drug Use Review program and electronic claim management system for outpatient drug claims Fed. Reg. 1992; 57:49397-49412
WHO. The role of the pharmacist in the health care system. WHO/PHARM/94.569, World Health Organization 1994
Moss RL, Garnett WR, Steiner KC. Physician attitudes toward pharmacists counseling patients on adverse drug reactions. Am J Hosp Pharm 1980;37:243-7.
Tanskanen P, Jäkälä J, Airaksinen M, Enlund H. Physicians’ views on co-operation with community pharmacists in Finland. J Soc Adm Pharm 1997;14:220-9.
Hannula A-M, Klaukka T, Eerikäinen S. Purpose of medication in Finland. Pharm J 248:466,1992
Gibbs S, Waters WE, George CF. The benefits of prescription information leaflets (2). Br J Clin Pharmacol 1989;28:345-51.
Ley P. Satisfaction, compliance and communication. Br J Clin Psychol 1982;21:241-54.
Morris LA, Kanouse DA. Informing patients about drug side effects. J Behav Med 1982;5:363-73.
Myers ED, Calvert EJ. Information, compliance and side effects: A study of patients on antidepressant medication. Br J Clin Pharmacol 1984;17:21-5.
Baker MJC. Medicine package inserts-How much to tell the patient. Pharmaceut Med 1991;5:175-92.
Vander-Stichele RH, De Potter B, Vyncke P, Bogaert MG. Attitude of physicians toward patient package inserts for medication information in Belgium. Patient Educ Couns 1996;28:5-13.
Faden RR, Becker C, Lewis C, Freeman J, Faden AI. Disclosure of information to patients in medical care. Med Care 1981;XIX:718-33.
Akaho E, Ahmad SR. A comparative study of Internet search engines by applying “cost effective treatment for myocardial infarction” as a search topic. Drug Inform J 1998;32:921-32
Hemminki E, Herxheimer A. Should drug information be an integral part of health care? J R Coll Physicians Lond 1996;30:104-6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanskanen, P., Airaksinen, M., Tanskanen, A. et al. Counselling patients on psychotropic medication: physicians' opinions on the role of community pharmacists. Pharm World Sci 22, 59–61 (2000). https://doi.org/10.1023/A:1008714922814
Issue Date:
DOI: https://doi.org/10.1023/A:1008714922814